ELISA / EIA / RIA Kits · ELISA / EIA kit · Cat. EK-059-02
Peptide YY (PYY) (3-36) (Human) – EIA Kit
Supplied as 96 wells per unit. Species: Human. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | EK-059-02 |
|---|---|
| Product type | ELISA / EIA / RIA Kits · ELISA / EIA kit |
| Peptide family | Peptide YY (PYY) |
| Species | Human |
| Unit size | 96 wells |
| Sensitivity | 0.06 ng/ml |
| Specificity | Peptide % Peptide YY (3-36) (Human) 100 Peptide YY (Human) 100 Peptide YY (3-34) (Human) 90 Peptide YY (3-34) G9R(Human) 81 Peptide YY (Rat, Mouse, Porcine, Canine) 26 Peptide YY (3-36) (Rat, Mouse, Porcine, Canine) 10 Neuropeptide Y (Porcine) 11 Pancreatic Polypeptide (Human) 0 Insulin (Human) 0 Glucagon (Human) 0 Amylin Amide (Human) 0 Substance P 0 |
| Linear Range | 0.06 - 0.67 ng/ml |
| Inter-Assay CV | <15% |
| Intra-Assay CV | <10% |
| Standard Curve | Contact us for technical specifications on this product. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. Drafts BC, Twomley KM, D'agostino R, et al. JACC Cardiovasc Imaging. 2013;6(8):877-85. Effects of vagus nerve preservation and vagotomy on peptide YY and body weight after subtotal gastrectomy. Kim HH, Park MI, Lee SH, et al. World J Gastroenterol. 2012;18(30):4044-50. Peptide hormone isoforms: N-terminally branched PYY3-36 isoforms give improved lipid and fat-cell metabolism in diet-induced obese mice. Pedersen SL, Sasikumar PG, Chelur S, et al. J Pept Sci. 2010;16(11):664-73. Ghrelin and obestatin circadian levels differentiate bingeing-purging from restrictive anorexia nervosa. Germain N, Galusca B, Grouselle D, et al. J Clin Endocrinol Metab. 2010;95(6):3057-62. Comparable effects of moderate intensity exercise on changes in anorectic gut hormone levels and energy intake to high intensity exercise. Ueda SY, Yoshikawa T, Katsura Y, Usui T, Fujimoto S. J Endocrinol. 2009;203(3):357-64. Effects of sucrose, glucose and fructose on peripheral and central appetite signals. Lindqvist A, Baelemans A, Erlanson-albertsson C. Regul Pept. 2008;150(1-3):26-32. Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases. Santoro S, Milleo FQ, Malzoni CE, et al. Obes Surg. 2008;18(1):17-26. Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery. Chen SC, Eiting K, Cui K, et al. J Pharm Sci. 2006;95(6):1364-71. Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons. Di francesco V, Zamboni M, Dioli A, et al. J Gerontol A Biol Sci Med Sci. 2005;60(12):1581-5. |
| Sample Extraction | Recommended |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Frequently asked
What is Peptide YY (PYY) (3-36) (Human) – EIA Kit?
Peptide YY (PYY) (3-36) (Human) – EIA Kit is a elisa / eia kit elisa / eia / ria kit listed under catalog number EK-059-02 in the Peptide YY (PYY) family, human sequence. It is supplied as 96 wells per unit for in vitro laboratory research.
What is the intended use of EK-059-02?
This catalog listing is for laboratory research use only. It is not represented as a drug, food, supplement, cosmetic or diagnostic product, and it is not offered for human or veterinary use.
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.